Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 12, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the „Company“ or „Innocan“) is pleased to announce that it has appointed Nissim Vasilevski as Analytical Chemist. In this role, Mr. Vasilevski will join the team developing analytical methods to accelerate this critical development and validations of Innocan Pharma’s liposome platform technology (LPT) product line,…